These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 34422969)
1. Low expression of IL6R predicts poor prognosis for lung adenocarcinoma. Sun G; Wang T; Shi M; Zhou H; Wang J; Huang Z; Zhang H; Shi J Ann Transl Med; 2021 Jul; 9(13):1057. PubMed ID: 34422969 [TBL] [Abstract][Full Text] [Related]
2. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma. Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203 [TBL] [Abstract][Full Text] [Related]
3. High SERPINH1 expression predicts poor prognosis in lung adenocarcinoma. Zhang H; Yan X; Gu H; Xue Q; Liu X J Thorac Dis; 2022 Dec; 14(12):4785-4802. PubMed ID: 36647484 [TBL] [Abstract][Full Text] [Related]
4. Development and validation of endoplasmic reticulum stress-related eight-gene signature for predicting the overall survival of lung adenocarcinoma. Lin L; Zhang W Transl Cancer Res; 2022 Jul; 11(7):1909-1924. PubMed ID: 35966313 [TBL] [Abstract][Full Text] [Related]
5. Construction of a prognostic model for lung adenocarcinoma based on bioinformatics analysis of metabolic genes. He J; Li W; Li Y; Liu G Transl Cancer Res; 2020 May; 9(5):3518-3538. PubMed ID: 35117717 [TBL] [Abstract][Full Text] [Related]
6. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma. Tian Q; Zhou Y; Zhu L; Gao H; Yang J Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361 [No Abstract] [Full Text] [Related]
7. Comprehensive analysis to identify a novel diagnostic marker of lung adenocarcinoma and its immune infiltration landscape. Zhu A; Pei D; Zong Y; Fan Y; Wei S; Xing Z; Song S; Wang X; Gao X Front Oncol; 2023; 13():1199608. PubMed ID: 37409245 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis. Wan Y; Wang X; Liu T; Fan T; Zhang Z; Wang B; Zhang B; Tian Z; Mao T; Gong Z; Zhang L Cancer Med; 2021 Jun; 10(12):4150-4163. PubMed ID: 33949150 [TBL] [Abstract][Full Text] [Related]
9. Integrated analysis and validation reveal ACAP1 as a novel prognostic biomarker associated with tumor immunity in lung adenocarcinoma. Wang N; Zhu L; Xu X; Yu C; Huang X Comput Struct Biotechnol J; 2022; 20():4390-4401. PubMed ID: 36051873 [TBL] [Abstract][Full Text] [Related]
10. Zheng X; Han L; Guan J; Chen C; Zhang Y; Zhang J; Zhang Y; Liu S; Su J; Liu M; Huang H Front Oncol; 2023; 13():1274439. PubMed ID: 38152367 [TBL] [Abstract][Full Text] [Related]
11. Identification of KRT80 as a Novel Prognostic and Predictive Biomarker of Human Lung Adenocarcinoma via Bioinformatics Approaches. Jiang J; Lu J; Feng Y; Zhao Y; Su J; Zeng T; Chen Y; Shen K; Jia Y; Lin S Comb Chem High Throughput Screen; 2024 Jun; ():. PubMed ID: 38910478 [TBL] [Abstract][Full Text] [Related]
12. Abnormal Expression and Prognostic Significance of Bone Morphogenetic Proteins and Their Receptors in Lung Adenocarcinoma. Xu Z; Chen C Biomed Res Int; 2021; 2021():6663990. PubMed ID: 34036102 [TBL] [Abstract][Full Text] [Related]
13. Establishment of a ferroptosis-related gene signature for prognosis in lung adenocarcinoma patients. Cai J; Li C; Li H; Wang X; Zhou Y PeerJ; 2021; 9():e11931. PubMed ID: 34434660 [TBL] [Abstract][Full Text] [Related]
14. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma. Ma C; Kang W; Yu L; Yang Z; Ding T Front Oncol; 2020; 10():590006. PubMed ID: 33363020 [TBL] [Abstract][Full Text] [Related]
15. Long Non-Coding RNA-TMPO-AS1 as ceRNA Binding to let-7c-5p Upregulates STRIP2 Expression and Predicts Poor Prognosis in Lung Adenocarcinoma. Wang J; Yuan Y; Tang L; Zhai H; Zhang D; Duan L; Jiang X; Li C Front Oncol; 2022; 12():921200. PubMed ID: 35774125 [TBL] [Abstract][Full Text] [Related]
16. Elevated Heterogeneous Nuclear Ribonucleoprotein C Expression Correlates With Poor Prognosis in Patients With Surgically Resected Lung Adenocarcinoma. Guo W; Huai Q; Zhang G; Guo L; Song P; Xue X; Tan F; Xue Q; Gao S; He J Front Oncol; 2020; 10():598437. PubMed ID: 33569346 [TBL] [Abstract][Full Text] [Related]
17. The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma. Chen A; Ding S; Shen X; Lin X Comput Math Methods Med; 2021; 2021():9932088. PubMed ID: 34367321 [TBL] [Abstract][Full Text] [Related]
18. A Prognostic 14-Gene Expression Signature for Lung Adenocarcinoma: A Study Based on TCGA Data Mining. Liu J; Hou S; Wang J; Chai Z; Hong X; Zhao T; Sun Z; Bai L; Gao H; Gao J; Chen G Oxid Med Cell Longev; 2020; 2020():8847226. PubMed ID: 33414898 [TBL] [Abstract][Full Text] [Related]
19. A new prognostic model for Li Q; Liu XL; Jiang N; Li QY; Song YX; Ke XX; Han H; Luo Q; Guo Q; Luo XY; Chen C J Thorac Dis; 2023 Apr; 15(4):1919-1934. PubMed ID: 37197482 [TBL] [Abstract][Full Text] [Related]
20. Loss of IL-34 Expression Indicates Poor Prognosis in Patients With Lung Adenocarcinoma. Wang Z; Zhu J; Wang T; Zhou H; Wang J; Huang Z; Zhang H; Shi J Front Oncol; 2021; 11():639724. PubMed ID: 34336646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]